Truvian Sciences Raises $105M Series C To Fund Development Of Point-Of-Care Testing Platform
Executive Summary
Truvian Sciences will use the proceeds to fund regulatory submission for its POC testing system in Europe and the US with hopes to bring to retailers, pharmacies, health systems in 2022.